Friday, 25 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14486
Articles
Company
Drug
Hengrui Remimazolam ICU Sedation NMPA Application Accepted
December 3, 2025
Others
Novo Nordisk CagriSema Pediatric Obesity Trial to Enroll 460 Children
December 3, 2025
Company
Drug
Antengene ATG-022 CLDN18.2 ADC Gets China Nod for Keytruda Combo in Gastric Cancer
December 3, 2025
Company
Drug
MSD MK-2214 Fast Track Alzheimer Data Positive
December 3, 2025
Policy / Regulatory
China Drug-Price Registration System Launches with First Batch of 10 Products
December 3, 2025
Company
Deals
3SBio HK$3.1B Placement Funds R&D Pipeline for 705, 706, 008
December 3, 2025
Company
Drug
Generate GB-0895 Asthma Phase III Trials to Enroll 1,600 Patients
December 3, 2025
Company
Drug
Henlius HLX14 Denosumab Biosimilar NDA Accepted by China CDE
December 3, 2025
Company
Deals
New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals
December 3, 2025
Company
Deals
Kura ziftomenib Sale Triggers $135M Kyowa-Kirin Payment
December 3, 2025
Company
Medical Device
Roche cobas-liat Whooping-Cough Test Secures FDA Clearance
December 3, 2025
Company
Drug
Henlius HLX37 Bispecific NMPA Approval Targets Advanced Solid Tumors
December 2, 2025
1
2
…
218
219
220
221
222
…
1,207
1,208
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?